Our Recommendations
- IMAI district clinician manual: hospital care for adolescents and adults: guidelines for the management of illnesses with limited-resources. Vol. 2 (2011)
- WHO guidelines for the treatment of Treponema pallidum (syphilis) (2016)
- Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection (2016)
- Guidelines for Addressing HIV in Humanitarian Settings (IASC) (2010)
- Clinical Guidelines for Antiretroviral Therapy Management for Displaced Populations Southern Africa (2007)
New Publications
- Framework for an Integrated Multisectoral Response to TB, HIV, STIS and Hepatitis in the WHO African Region 2021–2030 (2024)
- Men and HIV: evidence-based approaches and interventions (2023)
- Reducing antimicrobial resistance of treatable sexually transmitted infections in antenatal care (2022)
- Governance for the validation of elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus: (2022)
- Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Policy brief (2022)
Filter
107
Featured
Recommendations
13
New Publications
34
Language
Document type
No document type
67
Guidelines
29
Studies & Reports
7
Training Material
1
Resource Platforms
1
Infographics
1
Online Courses
1
Countries / Regions
Western and Central Europe
4
Latin America and the Carribbean
3
India
3
Zambia
2
Kenya
1
Senegal
1
Global
1
USA
1
South Africa
1
Eastern Europe
1
Authors & Publishers
Publication Years
Category
Toolboxes
Antiretroviral Treatment ART
15
Treatment Guidelines HIV
11
Treatment & Prevention
10
Clinical Aspects
8
HIV testing & services
7
Opportunistic Infections
7
Co-Morbidities (except TB)
7
ART Drug Resistance
6
Women
5
Prevention of mother-to-child transmission (PMTCT)
4
Clinical Aspects, Treatment & Prevention
2
Prevention Guidelines
2
HIV / AIDS
2
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
2
HIV and coinfection
2
HIV in Key Populations
2
Assessment & Studies
1
Surveillance
1
HIV surveillance
1
Humanitarian Settings
1
HIV
1
Others
1
General
1
HIV and COVID-19
1
COVID-19
1
Zoonoses
1
NTDs
1
Chagas
1
Access to treatment and laboratory
1
Online courses
1
General Aspects
1
Prophylactic Treatment
1
Latin America & the Carribean
1
HIV / AIDS
1
Testing Guidelines
1
TB/HIV Coinfection
1
HIV service delivery
1
TB
1
What health professionals need to know.
An online learning programme
A Learning Programme for Professionals
What health professionals need to know.
An online learning programme
Ces lignes directrices prônent une approche centrée sur la personne des informations stratégiques sur le VIH, ce qui implique de cesser de collecter des données agrégées dans les services (par exemple, le nombre de tests de dépistage du VIH administrés) pour s’intéresser au patient qui re...
Version 9.0
Octobre 2017
This concept note describes the methods used to assess the prevalence of any HIVDR and HIVDR by PMTCT exposure among children less than 18 months of age using remnant dried blood spot specimens from early infant diagnosis over a 12-month period
Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention,...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
Supplement
HIV testing services
December 2016
Guidelines
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
August 2015
HIV strategic information for impact
The new WHO guidelines recommend that people living with HIV be started on antiretrovirals (ARVs) as soon as possible after being diagnosed. Currently, many people living with the virus globally must wait until their CD4 counts fall to 500 to start treatment. According to the WHO, the move to early ...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
This series highlights current challenges to the management of Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, non-gonococcal urethris, bacterial vaginosis, syphilis and Trichomonas vaginalis. We have assembled a collection of state-of-the-art reviews that capture the latest evi...
